Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical drug development: an analysis of phase II trials, 1970-1985.
Marsoni S, Hoth D, Simon R, Leyland-Jones B, De Rosa M, Wittes RE. Marsoni S, et al. Cancer Treat Rep. 1987 Jan;71(1):71-80. Cancer Treat Rep. 1987. PMID: 3791270
Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer.
Marsoni S, Torri W, Taiana A, Gambino A, Grilli R, Liati P, Franzosi MG, Pistotti V, Parazzini F, Focarile F, et al. Marsoni S, et al. Ann Oncol. 1990 Sep;1(5):343-50. doi: 10.1093/oxfordjournals.annonc.a057772. Ann Oncol. 1990. PMID: 2148106
Dilemmas in the development of cytoxic drug analogues.
Marsoni S. Marsoni S. Eur J Cancer. 1992;28A(10):1594-5. doi: 10.1016/0959-8049(92)90047-6. Eur J Cancer. 1992. PMID: 1389470 No abstract available.
Dose-response relationship in phase i clinical trials: a European Drug Development Network (EDDN) Collaboration Study.
Moreno García V, Olmos D, Gomez-Roca C, Cassier PA, Morales-Barrera R, Del Conte G, Gallerani E, Brunetto AT, Schöffski P, Marsoni S, Schellens JH, Penel N, Voest E, Evans J, Plummer R, Wilson RH, Soria JC, Tabernero J, Verweij J, Kaye SB. Moreno García V, et al. Among authors: marsoni s. Clin Cancer Res. 2014 Nov 15;20(22):5663-71. doi: 10.1158/1078-0432.CCR-14-0719. Epub 2014 Sep 24. Clin Cancer Res. 2014. PMID: 25252757
Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
Macdonald JS, Marsoni S, Bruno S, Poster D. Macdonald JS, et al. Among authors: marsoni s. Recent Results Cancer Res. 1982;80:323-30. doi: 10.1007/978-3-642-81685-7_52. Recent Results Cancer Res. 1982. PMID: 6977170
Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
Pisoni MB, Libretti A, Piazza E, Vago G, Scapaticci R, Bianchi C, Tomirotti M, Scanni A, Calzavara MP, Cassani L, Scarpazza G, Marsoni S, Morasca L. Pisoni MB, et al. Among authors: marsoni s. Cancer Treat Rep. 1981 Jul-Aug;65(7-8):731-2. Cancer Treat Rep. 1981. PMID: 6788372 No abstract available.
Teniposide: a review of 12 years of experience.
O'Dwyer PJ, Alonso MT, Leyland-Jones B, Marsoni S. O'Dwyer PJ, et al. Among authors: marsoni s. Cancer Treat Rep. 1984 Dec;68(12):1455-66. Cancer Treat Rep. 1984. PMID: 6391663 Review. No abstract available.
Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S, Wittes R. Marsoni S, et al. Cancer Treat Rep. 1984 Jan;68(1):77-85. Cancer Treat Rep. 1984. PMID: 6362870 Clinical Trial. No abstract available.
Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: a phase II study.
Libretti A, Piazza E, Scanni A, Tomirotti M, Biraghi M, Scapaticci R, Bianchi C, Restelli G, Scarpazza G, Calzavara MP, Marsoni S, Morasca L. Libretti A, et al. Among authors: marsoni s. Cancer Treat Rep. 1981 Jan-Feb;65(1-2):171-2. Cancer Treat Rep. 1981. PMID: 6164485 No abstract available.
The phase II trial.
Wittes RE, Marsoni S, Simon R, Leyland-Jones B. Wittes RE, et al. Among authors: marsoni s. Cancer Treat Rep. 1985 Nov;69(11):1235-9. Cancer Treat Rep. 1985. PMID: 4092188 No abstract available.
123 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback